# Optical Imaging as a Tool for Monitoring Brain Function in Fragile X Syndrome

> **NCT06293027** · — · UNKNOWN · sponsor: **IRCCS Fondazione Stella Maris** · enrollment: 40 (estimated)

## Conditions studied

- Fragile X Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06293027
- **Lead sponsor:** IRCCS Fondazione Stella Maris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06293027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06293027, "Optical Imaging as a Tool for Monitoring Brain Function in Fragile X Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06293027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*